General
Preferred name
SECNIDAZOLE
Synonyms
PM-185184 ()
RP-14539 ()
1-(2-Methyl-5-nitro-imidazol-1-yl)-propan-2-ol ()
PM 185184, RP 14539 ()
Flagentyl ()
SYM-1219 ()
Deprozol ()
NSC-759812 ()
Secnidal ()
Secnidazole anhydrous ()
Secnol ()
Sabima ()
Solosec ()
RP 14539 ()
Ornidazole metabolite m4 ()
Secnidazole ()
P&D ID
PD000955
CAS
3366-95-8
Tags
available
prodrug
drug
Approved by
FDA
First approval
2017
Drug Status
approved
Drug indication
Amoebiasis
Bacterial vaginosis
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Cell lines
0
Organisms
3
Compound Sets
20
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Pandemic Response Box
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
33
Properties
(calculated by RDKit )
Molecular Weight
185.08
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
1
Aromatic Ring Count
1
cLogP
0.48
TPSA
81.19
Fraction CSP3
0.57
Chiral centers
1.0
Largest ring
5.0
QED
0.55
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Microbiology&virology
Anti-infection
Target
antibiotic
Bacterial
Parasite
MOA
Antibiotic
Source data